British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
Gespeichert in:
| Veröffentlicht in: | British journal of dermatology (1951) 2009-11, Vol.161 (5), p.987-1019 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1019 |
|---|---|
| container_issue | 5 |
| container_start_page | 987 |
| container_title | British journal of dermatology (1951) |
| container_volume | 161 |
| creator | Smith, C.H. Anstey, A.V. Barker, J.N.W.N. Burden, A.D. Chalmers, R.J.G. Chandler, D.A. Finlay, A.Y. Griffiths, C.E.M. Jackson, K. McHugh, N.J. McKenna, K.E. Reynolds, N.J. Ormerod, A.D. |
| description | |
| doi_str_mv | 10.1111/j.1365-2133.2009.09505.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733688035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733688035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4725-3b6db79e7045c632d72db347759bf2d8e919cae68501f46ae37292c1b2f43f633</originalsourceid><addsrcrecordid>eNqNkE9T3CAYhxmnHV2tX8Hh5inxhTdAOPSgbqt2nLaH_jkyJCGWbTaskG3Xb29iduy1XGDm93te4CGEMsjZuC5WOUMpMs4Qcw6gc9ACRL47IIvX4A1ZAIDKQEs8IscprQAYgoBDcsR0KRQHtSDmKvrBp1_0MqVQezv40NPQ0qWLazuELjz4NKRz-rD1jet87xJtQ6SVf4lq6vvBxT-un7g52qQQvU0-0ell78jb1nbJne73E_L944dv17fZ_Zebu-vL-6wuFBcZVrKplHYKClFL5I3iTYWFUkJXLW9Kp5murZOlANYW0jpUXPOaVbwtsJWIJ-R8nruJ4XHr0mDWPtWu62zvwjYZhSjLElCMzXJu1jGkFF1rNtGvbXwyDMxk16zMJNFMEs30B_Ni1-xG9Gx_ybZau-YfuNc5Ft7Phb--c0__PdhcfVpOp5HPZn6U7navvI2_jVSohPn5-cYsVQE_9Fc0t_gMO8eXkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733688035</pqid></control><display><type>article</type><title>British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Smith, C.H. ; Anstey, A.V. ; Barker, J.N.W.N. ; Burden, A.D. ; Chalmers, R.J.G. ; Chandler, D.A. ; Finlay, A.Y. ; Griffiths, C.E.M. ; Jackson, K. ; McHugh, N.J. ; McKenna, K.E. ; Reynolds, N.J. ; Ormerod, A.D.</creator><creatorcontrib>Smith, C.H. ; Anstey, A.V. ; Barker, J.N.W.N. ; Burden, A.D. ; Chalmers, R.J.G. ; Chandler, D.A. ; Finlay, A.Y. ; Griffiths, C.E.M. ; Jackson, K. ; McHugh, N.J. ; McKenna, K.E. ; Reynolds, N.J. ; Ormerod, A.D. ; Chair of Guideline Group</creatorcontrib><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/j.1365-2133.2009.09505.x</identifier><identifier>PMID: 19857207</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>adalimumab ; Adolescent ; Anti-Inflammatory Agents - adverse effects ; Anti-Inflammatory Agents - therapeutic use ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Biological Therapy - methods ; biologics ; Child ; Child, Preschool ; Dermatologic Agents - adverse effects ; Dermatologic Agents - therapeutic use ; Dermatology - methods ; Drug Therapy, Combination ; efalizumab ; etanercept ; Female ; guideline ; Humans ; infliximab ; Male ; Pregnancy ; psoriasis ; Psoriasis - complications ; Psoriasis - therapy ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; ustekinumab ; Virus Diseases - complications ; Virus Diseases - drug therapy</subject><ispartof>British journal of dermatology (1951), 2009-11, Vol.161 (5), p.987-1019</ispartof><rights>2009 The Authors. Journal Compilation © 2009 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4725-3b6db79e7045c632d72db347759bf2d8e919cae68501f46ae37292c1b2f43f633</citedby><cites>FETCH-LOGICAL-c4725-3b6db79e7045c632d72db347759bf2d8e919cae68501f46ae37292c1b2f43f633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2133.2009.09505.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2133.2009.09505.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19857207$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, C.H.</creatorcontrib><creatorcontrib>Anstey, A.V.</creatorcontrib><creatorcontrib>Barker, J.N.W.N.</creatorcontrib><creatorcontrib>Burden, A.D.</creatorcontrib><creatorcontrib>Chalmers, R.J.G.</creatorcontrib><creatorcontrib>Chandler, D.A.</creatorcontrib><creatorcontrib>Finlay, A.Y.</creatorcontrib><creatorcontrib>Griffiths, C.E.M.</creatorcontrib><creatorcontrib>Jackson, K.</creatorcontrib><creatorcontrib>McHugh, N.J.</creatorcontrib><creatorcontrib>McKenna, K.E.</creatorcontrib><creatorcontrib>Reynolds, N.J.</creatorcontrib><creatorcontrib>Ormerod, A.D.</creatorcontrib><creatorcontrib>Chair of Guideline Group</creatorcontrib><title>British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><subject>adalimumab</subject><subject>Adolescent</subject><subject>Anti-Inflammatory Agents - adverse effects</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Biological Therapy - methods</subject><subject>biologics</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dermatologic Agents - adverse effects</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Dermatology - methods</subject><subject>Drug Therapy, Combination</subject><subject>efalizumab</subject><subject>etanercept</subject><subject>Female</subject><subject>guideline</subject><subject>Humans</subject><subject>infliximab</subject><subject>Male</subject><subject>Pregnancy</subject><subject>psoriasis</subject><subject>Psoriasis - complications</subject><subject>Psoriasis - therapy</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>ustekinumab</subject><subject>Virus Diseases - complications</subject><subject>Virus Diseases - drug therapy</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE9T3CAYhxmnHV2tX8Hh5inxhTdAOPSgbqt2nLaH_jkyJCGWbTaskG3Xb29iduy1XGDm93te4CGEMsjZuC5WOUMpMs4Qcw6gc9ACRL47IIvX4A1ZAIDKQEs8IscprQAYgoBDcsR0KRQHtSDmKvrBp1_0MqVQezv40NPQ0qWLazuELjz4NKRz-rD1jet87xJtQ6SVf4lq6vvBxT-un7g52qQQvU0-0ell78jb1nbJne73E_L944dv17fZ_Zebu-vL-6wuFBcZVrKplHYKClFL5I3iTYWFUkJXLW9Kp5murZOlANYW0jpUXPOaVbwtsJWIJ-R8nruJ4XHr0mDWPtWu62zvwjYZhSjLElCMzXJu1jGkFF1rNtGvbXwyDMxk16zMJNFMEs30B_Ni1-xG9Gx_ybZau-YfuNc5Ft7Phb--c0__PdhcfVpOp5HPZn6U7navvI2_jVSohPn5-cYsVQE_9Fc0t_gMO8eXkA</recordid><startdate>200911</startdate><enddate>200911</enddate><creator>Smith, C.H.</creator><creator>Anstey, A.V.</creator><creator>Barker, J.N.W.N.</creator><creator>Burden, A.D.</creator><creator>Chalmers, R.J.G.</creator><creator>Chandler, D.A.</creator><creator>Finlay, A.Y.</creator><creator>Griffiths, C.E.M.</creator><creator>Jackson, K.</creator><creator>McHugh, N.J.</creator><creator>McKenna, K.E.</creator><creator>Reynolds, N.J.</creator><creator>Ormerod, A.D.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200911</creationdate><title>British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009</title><author>Smith, C.H. ; Anstey, A.V. ; Barker, J.N.W.N. ; Burden, A.D. ; Chalmers, R.J.G. ; Chandler, D.A. ; Finlay, A.Y. ; Griffiths, C.E.M. ; Jackson, K. ; McHugh, N.J. ; McKenna, K.E. ; Reynolds, N.J. ; Ormerod, A.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4725-3b6db79e7045c632d72db347759bf2d8e919cae68501f46ae37292c1b2f43f633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>adalimumab</topic><topic>Adolescent</topic><topic>Anti-Inflammatory Agents - adverse effects</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Biological Therapy - methods</topic><topic>biologics</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dermatologic Agents - adverse effects</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Dermatology - methods</topic><topic>Drug Therapy, Combination</topic><topic>efalizumab</topic><topic>etanercept</topic><topic>Female</topic><topic>guideline</topic><topic>Humans</topic><topic>infliximab</topic><topic>Male</topic><topic>Pregnancy</topic><topic>psoriasis</topic><topic>Psoriasis - complications</topic><topic>Psoriasis - therapy</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>ustekinumab</topic><topic>Virus Diseases - complications</topic><topic>Virus Diseases - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, C.H.</creatorcontrib><creatorcontrib>Anstey, A.V.</creatorcontrib><creatorcontrib>Barker, J.N.W.N.</creatorcontrib><creatorcontrib>Burden, A.D.</creatorcontrib><creatorcontrib>Chalmers, R.J.G.</creatorcontrib><creatorcontrib>Chandler, D.A.</creatorcontrib><creatorcontrib>Finlay, A.Y.</creatorcontrib><creatorcontrib>Griffiths, C.E.M.</creatorcontrib><creatorcontrib>Jackson, K.</creatorcontrib><creatorcontrib>McHugh, N.J.</creatorcontrib><creatorcontrib>McKenna, K.E.</creatorcontrib><creatorcontrib>Reynolds, N.J.</creatorcontrib><creatorcontrib>Ormerod, A.D.</creatorcontrib><creatorcontrib>Chair of Guideline Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, C.H.</au><au>Anstey, A.V.</au><au>Barker, J.N.W.N.</au><au>Burden, A.D.</au><au>Chalmers, R.J.G.</au><au>Chandler, D.A.</au><au>Finlay, A.Y.</au><au>Griffiths, C.E.M.</au><au>Jackson, K.</au><au>McHugh, N.J.</au><au>McKenna, K.E.</au><au>Reynolds, N.J.</au><au>Ormerod, A.D.</au><aucorp>Chair of Guideline Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2009-11</date><risdate>2009</risdate><volume>161</volume><issue>5</issue><spage>987</spage><epage>1019</epage><pages>987-1019</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19857207</pmid><doi>10.1111/j.1365-2133.2009.09505.x</doi><tpages>33</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0963 |
| ispartof | British journal of dermatology (1951), 2009-11, Vol.161 (5), p.987-1019 |
| issn | 0007-0963 1365-2133 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733688035 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current) |
| subjects | adalimumab Adolescent Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Biological Therapy - methods biologics Child Child, Preschool Dermatologic Agents - adverse effects Dermatologic Agents - therapeutic use Dermatology - methods Drug Therapy, Combination efalizumab etanercept Female guideline Humans infliximab Male Pregnancy psoriasis Psoriasis - complications Psoriasis - therapy Tumor Necrosis Factor-alpha - antagonists & inhibitors ustekinumab Virus Diseases - complications Virus Diseases - drug therapy |
| title | British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T00%3A59%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=British%20Association%20of%20Dermatologists'%20guidelines%20for%20biologic%20interventions%20for%20psoriasis%202009&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Smith,%20C.H.&rft.aucorp=Chair%20of%20Guideline%20Group&rft.date=2009-11&rft.volume=161&rft.issue=5&rft.spage=987&rft.epage=1019&rft.pages=987-1019&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/j.1365-2133.2009.09505.x&rft_dat=%3Cproquest_cross%3E733688035%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733688035&rft_id=info:pmid/19857207&rfr_iscdi=true |